TY - JOUR
T1 - The effect of preoperative apolipoprotein a-I on the prognosis of surgical renal cell carcinoma a retrospective large sample study
AU - Guo, Shengjie
AU - He, Xiaobo
AU - Chen, Qian
AU - Yang, Guangwei
AU - Yao, Kai
AU - Dong, Pei
AU - Ye, Yunlin
AU - Chen, Dong
AU - Zhang, Zhiling
AU - Qin, Zike
AU - Liu, Zhuowei
AU - Li, Zaishang
AU - Xue, Yunfei
AU - Zhang, Meng
AU - Liu, Ruiwu
AU - Zhou, Fangjian
AU - Han, Hui
PY - 2016
Y1 - 2016
N2 - The prognostic value of serum lipid-profile in renal cell cancer (RCC) remains unknown. The purpose of the study is to explore the association between the serum lipid-profile and RCC patients. The levels of preoperative serum lipid-profile (including cholesterol, triglycerides, high-density lipoprotein-cholesterol [HDL-C], lowdensity lipoprotein-cholesterol [LDL-C], apolipoprotein A-I [ApoAI], and apolipoprotein B [ApoB]) were retrospectively performed in 786 patients with RCC. The cutoff values of the lipids were determined by the receiver-operating characteristic (ROC) curve analysis. Univariate and multivariate Cox regression analyses were performed to investigate the prognostic value of serum lipids in RCC. Combined ROC analysis and univariate and multivariate Cox regression analyses, for overall survival (OS), revealed patients with low ApoA-I (<1.04) had significantly lower OS than the high ApoA-I (≥1.04) group (multivariate Cox regression analyses, hazard ratio [HR], 0.57; P=0.003). Not only in the whole RCC cohort but also in the subgroups stratified according to the pT1-2 (P=0.002), pN0 (P<0.001), and pM0 (P=0.001) status, respectively. Moreover, in the 755 patients with nonmetastasis, the low ApoA-I group was also associated with shortened disease-free survival (DFS) time compared to the high ApoA-I group (multivariate Cox regression analyses, HR, 0.65; P=0.033). However, the other lipids were not independent prognostic factors for surgical RCC. An elevated level of preoperative ApoA-I was demonstrated to be related with better survival in patients with surgical RCC. Measuring the preoperative ApoA-I might be a simple way for finding the poor prognostic patients who should enrolled in further clinical trials and management.
AB - The prognostic value of serum lipid-profile in renal cell cancer (RCC) remains unknown. The purpose of the study is to explore the association between the serum lipid-profile and RCC patients. The levels of preoperative serum lipid-profile (including cholesterol, triglycerides, high-density lipoprotein-cholesterol [HDL-C], lowdensity lipoprotein-cholesterol [LDL-C], apolipoprotein A-I [ApoAI], and apolipoprotein B [ApoB]) were retrospectively performed in 786 patients with RCC. The cutoff values of the lipids were determined by the receiver-operating characteristic (ROC) curve analysis. Univariate and multivariate Cox regression analyses were performed to investigate the prognostic value of serum lipids in RCC. Combined ROC analysis and univariate and multivariate Cox regression analyses, for overall survival (OS), revealed patients with low ApoA-I (<1.04) had significantly lower OS than the high ApoA-I (≥1.04) group (multivariate Cox regression analyses, hazard ratio [HR], 0.57; P=0.003). Not only in the whole RCC cohort but also in the subgroups stratified according to the pT1-2 (P=0.002), pN0 (P<0.001), and pM0 (P=0.001) status, respectively. Moreover, in the 755 patients with nonmetastasis, the low ApoA-I group was also associated with shortened disease-free survival (DFS) time compared to the high ApoA-I group (multivariate Cox regression analyses, HR, 0.65; P=0.033). However, the other lipids were not independent prognostic factors for surgical RCC. An elevated level of preoperative ApoA-I was demonstrated to be related with better survival in patients with surgical RCC. Measuring the preoperative ApoA-I might be a simple way for finding the poor prognostic patients who should enrolled in further clinical trials and management.
UR - http://www.scopus.com/inward/record.url?scp=84962195221&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962195221&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000003147
DO - 10.1097/MD.0000000000003147
M3 - Article
C2 - 27015197
AN - SCOPUS:84962195221
VL - 95
JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
SN - 0025-7974
IS - 12
M1 - e3147
ER -